Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Validation of a Diagnostic and/or Prognostic Marker for Alzheimer's Disease by Fecal Determination of Amyloid Peptides and Tau Proteins

NCT06481878 is registered in ClinicalTrials.gov with University Hospital, Grenoble as lead sponsor.

NCT NCT06481878
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06481878 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Validation of a Diagnostic and/or Prognostic Marker for Alzheimer's Disease by Fecal Determination of Amyloid Peptides and Tau Proteins
Lead sponsor
University Hospital, Grenoble
Phase
Observational
Overall status
Recruiting
Start date
October 11, 2024
Completion date
October 6, 2027
Enrollment
115 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease